---
title: "Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients"
ocid: "ocds-kuma6s-141500"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-141500"
markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-141500.md"
json_url: "https://d3tenders.com/contract/ocds-kuma6s-141500.json"
source: "Sell2Wales"
current_stage: "Award"
buyer: "NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)"
published: "2024-05-15"
---

# Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients

Buyer: NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)  
Current stage: Award  
OCID: ocds-kuma6s-141500

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-141500)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-141500.json)

## Summary

The procurement process for the purchase of Rare or Inherited Disease Test Directory testing for Welsh patients is led by NHS Wales Shared Services Partnership-Procurement Services. The procurement stage is complete, with the award made to CeGaT GmbH. The tender involves the healthcare industry category and is located in Cardiff, UK. The procurement method used was a limited award procedure without prior publication of a call for competition. Key dates include the contract's signing on May 15, 2024, and the estimated contract start in June 2024.

This tender for genetic testing services presents opportunities for businesses in the health sector, particularly those with expertise in rare disease diagnostics. The contract aims to ensure equity of access to genomic testing for Welsh patients seeking timely genetic diagnoses. Businesses well-suited to compete would possess capabilities in whole exome sequencing, virtual panel analysis, MLPA, and single gene testing. The bespoke nature of the procurement allows for a direct award approach, reducing additional expenditures and offering a unique opportunity for service providers to contribute to enhancing healthcare delivery in Wales.

## Notice

In-line with All Wales Medical genomic Service's (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.

### Lot Information

Lot 1

NWSSP Procurement Services intends to award a contract on behalf of Cardiff and Vale University Health Board, AWMGS, for the supply of whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing from CeGAT. The contract is estimated to commence in June 2024, for a period of two years.

### Procurement Information

All Wales Genomics Service (AWMGS) is commissioned by the NHS Wales Joint Commissioning Committee (JCC) (formally WHSSC) to provide genetic testing for Welsh patients which is equitable to the Clinical Indications stated in the NHSE Rare and Inherited Disease Test Directory. NHS E patients can currently access a range of Whole Genome Sequencing (WGS) and Whole Exome Sequencing (WES) tests for rare and inherited diseases delivered from within the 7 Genomic Laboratory Hub service model. As a single service provider within Wales, there is necessarily a reliance on external services to enable delivery of the entire Test Directory. In-house service developments are ongoing to increase the number of genetic tests delivered from within AWMGS and there are significant repatriations planned but these will not go-live until 2025 - 27 (services will be introduced over a 18-24-month basis) following completion of the GLIMS and relocation projects. Due to a lack of testing capacity of NHS England laboratories to carry out the WGS based tests, reliance has been made on incumbent private provider CeGat. Given current organisational pressures to deliver an effective service, it has been noted that additional capacity be provided to supress demand. Equally, CeGAT have absorbed the sample courier responsibilities as part of the sample pathway, which has reduced the impact on AWMGS staffing. There have also been a number of MDT mechanisms established to ensure that reporting of patient results is consistent between AWMGS and CeGaT. This is critical to service delivery as it ensures equity for patients that are being referred to AWMGS and means that they are not at risk of receiving differing testing approaches depending on if testing was delivered in house or via an external laboratory. This level of bespoke service and customisation meeting the specification defined in the AWMGS standard operating procedures and consistent with UK best practice reporting guidelines is essential to delivering a robust and equitable, high-quality service. Given the bespoke attributes of the current contract, a direct award approach negates additional expenditure of the service and extended timelines.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Sell2Wales |
| Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=141500 |
| Notice type | OJEU - F15 - Voluntary Ex Ante Transparency Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 15 May 2024 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 15 May 2024 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £660,000 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) |
| Locality | CARDIFF |
| Post town | Cardiff |
| Postcode | CF15 7QZ |
| Country | Wales |
| ITL 1 | TLL Wales |
| ITL 2 | TLL5 South East Wales |
| ITL 3 | TLL51 Central Valleys and Bridgend |
| Local authority | Rhondda Cynon Taf |
| Electoral ward | Taff's Well |
| Westminster constituency | Cardiff North |
| Delivery location | TLL22 Cardiff and Vale of Glamorgan |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | CEGAT |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33910000 - Pathology dissection instruments and supplies

## Release History

- 15 May 2024 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=141500

## Documents

- https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=MAY478032
  Purchase of Rare or Inherited Disease Test Directory testing for Welsh patients - In-line with All Wales Medical genomic Service's (AWMGS) commissioning model, AWMGS will procure from CeGaT whole exom sequencing (WES) for trio or singleton virtual panel analysis, MLPA and single gene testing for patients where this testing cannot be accessed within the NHS E laboratory network. This genetic testing will ensure equity of access to genomic testing for Welsh patients and meet their need to seek a timely genetic diagnosis for their rare or inherited disease.

## Notice URLs

- http://nwssp.nhs.wales/ourservices/procurement-services/
- http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=141500
- https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-141500

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-141500. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-141500.json.